These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23752663)
1. Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison. Gellad WF; Donohue JM; Zhao X; Mor MK; Thorpe CT; Smith J; Good CB; Fine MJ; Morden NE Ann Intern Med; 2013 Jul; 159(2):105-14. PubMed ID: 23752663 [TBL] [Abstract][Full Text] [Related]
2. Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D. Dusetzina SB; Sarpatwari A; Carrier MA; Hansen RA; Keating NL; Huskamp HA JAMA Intern Med; 2021 Dec; 181(12):1605-1611. PubMed ID: 34661600 [TBL] [Abstract][Full Text] [Related]
3. Impact of formulary restrictions on medication use and costs. Shen X; Stuart BC; Powers CA; Tom SE; Magder LS; Perfetto EM Am J Manag Care; 2017 Aug; 23(8):e265-e274. PubMed ID: 29087150 [TBL] [Abstract][Full Text] [Related]
4. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents. Sacks CA; Lee CC; Kesselheim AS; Avorn J JAMA; 2018 Aug; 320(7):650-656. PubMed ID: 30140875 [TBL] [Abstract][Full Text] [Related]
5. Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol-Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database. Sumarsono A; Lalani HS; Vaduganathan M; Navar AM; Fonarow GC; Das SR; Pandey A JAMA Cardiol; 2021 Jan; 6(1):92-96. PubMed ID: 32902560 [TBL] [Abstract][Full Text] [Related]
6. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs. Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379 [TBL] [Abstract][Full Text] [Related]
7. Sources of regional variation in Medicare Part D drug spending. Donohue JM; Morden NE; Gellad WF; Bynum JP; Zhou W; Hanlon JT; Skinner J N Engl J Med; 2012 Feb; 366(6):530-8. PubMed ID: 22316446 [TBL] [Abstract][Full Text] [Related]
8. Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System. Gellad WF; Good CB; Lowe JC; Donohue JM Am J Manag Care; 2010 Oct; 16(10):741-50. PubMed ID: 20964470 [TBL] [Abstract][Full Text] [Related]
9. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit. Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812 [TBL] [Abstract][Full Text] [Related]
10. In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions. Hoadley JF; Merrell K; Hargrave E; Summer L Health Aff (Millwood); 2012 Oct; 31(10):2266-75. PubMed ID: 23048108 [TBL] [Abstract][Full Text] [Related]
11. The association of Medicare drug coverage with use of evidence-based medications in the Veterans Health Administration. Johnson ML; Petersen LA; Sundaravaradan R; Byrne MM; Hasche JC; Osemene NI; Wei II; Morgan RO Ann Pharmacother; 2009 Oct; 43(10):1565-75. PubMed ID: 19706740 [TBL] [Abstract][Full Text] [Related]
12. Medicare Part D Plans Rarely Cover Brand-Name Drugs When Generics Are Available. Dusetzina SB; Cubanski J; Nshuti L; True S; Hoadley J; Roberts D; Neuman T Health Aff (Millwood); 2020 Aug; 39(8):1326-1333. PubMed ID: 32744944 [TBL] [Abstract][Full Text] [Related]
13. Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Goedken AM; Urmie JM; Farris KB; Doucette WR Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109 [TBL] [Abstract][Full Text] [Related]
14. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts. Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336 [TBL] [Abstract][Full Text] [Related]
15. Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study. Moyo P; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Hale JA; Mor MK; Radomski TR; Donohue JM; Hausmann LRM; Hanlon JT; Good CB; Fine MJ; Gellad WF Ann Intern Med; 2019 Apr; 170(7):433-442. PubMed ID: 30856660 [TBL] [Abstract][Full Text] [Related]
16. Impact of medicare part D plan features on use of generic drugs. Tang Y; Gellad WF; Men A; Donohue JM Med Care; 2014 Jun; 52(6):541-8. PubMed ID: 24824538 [TBL] [Abstract][Full Text] [Related]
17. Estimation of Medicare Part D Spending on Insulin for Patients With Diabetes Using Negotiated Prices and a Defined Formulary. Feldman WB; Rome BN; Lehmann LS; Kesselheim AS JAMA Intern Med; 2020 Apr; 180(4):597-601. PubMed ID: 32011624 [TBL] [Abstract][Full Text] [Related]
18. Part D's underuse of generics wastes $1B per year. Manag Care; 2013 Jul; 22(7):68. PubMed ID: 23940871 [No Abstract] [Full Text] [Related]
19. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350 [TBL] [Abstract][Full Text] [Related]
20. Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs. Gastala NM; Wingrove P; Gaglioti A; Petterson S; Bazemore A Health Aff (Millwood); 2016 Jul; 35(7):1237-40. PubMed ID: 27385239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]